Recent posts

TypePostAuthorRepliesLast updated
Blog entryJanuary 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer thiru05 hours 59 min ago
Blog entry13 May 2014: WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation thiru05 days 10 hours ago
Blog entryTDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up thiru02 weeks 10 hours ago
PageThe Big Idea: Prizes to Stimulate R&D for New Medicines thiru02 weeks 2 days ago
Book pageJames Love, Director James Love02 weeks 2 days ago
Blog entryOMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions James Love02 weeks 3 days ago
Book pageCPTech's 2003 reports for the RSA Competition Commission, in Hazel Tau et al.v GSK, Boehringer, et al KEI Staff02 weeks 5 days ago
PageThe USTR Special 301 Reports, 1989 to 2014 James Love02 weeks 6 days ago
Blog entryGilead's US patient access programs for Sovaldi Elizabeth Rajasingh03 weeks 1 day ago
Blog entryWIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources thiru03 weeks 5 days ago
Blog entrySome recent cancer drug prices James Love03 weeks 6 days ago
Blog entryMoney speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP KEI Staff04 weeks 1 day ago
Blog entryUS proposal: IGC Work Plan for 2015-Is the IGC train leaving the station? thiru04 weeks 1 day ago
Blog entryGilead's MPP license for tenofovir alafenamide (TAF) patents James Love04 weeks 4 days ago
PageElizabeth Rajasingh, Perls Fellow Elizabeth Rajasingh04 weeks 5 days ago
Book pageHepatitis C Claire Cassedy04 weeks 5 days ago
StoryTimeline of privileges regarding the commercialization and use of knowledge. Part 2: 1980 to 1999 KEI Staff04 weeks 5 days ago
Blog entryHepatitis research and development timeline James Love05 weeks 9 hours ago
PageAbbott sought compulsory license in 2007 US patent dispute thiru05 weeks 1 day ago
Book pageHepatitis James Love05 weeks 1 day ago
StoryTimelines James Love05 weeks 2 days ago
Blog entry KEI asks FTC to investigate Shire decision to abandon efforts to compete in US market for Fabry’s disease treatments James Love05 weeks 4 days ago
Blog entry Hepatitis C Virus patent assignments: patents with HCV in the patent claim James Love05 weeks 5 days ago
Blog entryNew UK Parliamentary report on Global TB urges the United Kingdom to explore a WTO Agreement on the Provision of Public Goods thiru06 weeks 1 day ago
Blog entryKEI Policy Brief: Non-Voluntary use of HCV patents in the United States James Love06 weeks 4 days ago